Acrivon Therapeutics

ACRV

Acrivon Therapeutics has been a target of short sellers for a while. The current short interest of 2.66% is significantly below the average of the last 12 months (6.36%).

Short Interest Trend

Share Price

Total NSP

2.66%

-0.22%

vs. last month

Also interesting? All insider buys at Acrivon Therapeutics

Found an error? Questions? Ideas?